| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.93B | 138.43B | 131.66B | 133.52B | 113.72B | 107.09B |
| Gross Profit | 25.36B | 25.62B | 23.55B | 22.88B | 22.44B | 19.83B |
| EBITDA | 20.61B | 20.89B | 18.75B | 17.89B | 17.56B | 15.86B |
| Net Income | 14.17B | 15.22B | 12.82B | 12.29B | 12.01B | 10.80B |
Balance Sheet | ||||||
| Total Assets | 167.97B | 185.30B | 172.95B | 168.15B | 156.03B | 140.18B |
| Cash, Cash Equivalents and Short-Term Investments | 72.91B | 95.82B | 82.65B | 84.17B | 74.60B | 65.17B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 44.78B | 50.75B | 50.64B | 55.05B | 53.59B | 48.56B |
| Stockholders Equity | 123.19B | 134.55B | 122.31B | 113.09B | 102.43B | 91.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 16.72B | 2.29B | 11.50B | 10.46B | 3.69B |
| Operating Cash Flow | 0.00 | 17.24B | 2.65B | 11.70B | 10.59B | 3.77B |
| Investing Cash Flow | 0.00 | -7.55B | -34.43B | -247.00M | 123.00M | -123.00M |
| Financing Cash Flow | 0.00 | -3.52B | -3.74B | -1.88B | -1.28B | -1.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
87 Outperform | ¥133.17B | 8.72 | ― | 2.81% | 5.14% | 18.79% | |
79 Outperform | ¥148.84B | 13.78 | ― | 3.22% | 14.62% | 33.65% | |
79 Outperform | ¥130.77B | 15.33 | ― | 2.14% | 4.78% | 50.65% | |
77 Outperform | ¥93.66B | 12.37 | ― | 4.38% | -6.07% | 44.83% | |
65 Neutral | ¥109.34B | 10.83 | ― | 2.13% | 3.17% | 77.09% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥110.19B | 12.95 | ― | 3.81% | -9.72% | -31.50% |